{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-329618","form_type":"8-K","ticker":"INDV","cik":"0001625297","company_name":"Indivior Pharmaceuticals, Inc.","filed_at":"2026-08-03T12:32:42+00:00","discovered_at":"2026-08-03T12:35:01.502431+00:00","generated_at":"2026-08-03T12:35:09.826883+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"medium","headline":"Indivior and Supernus announce merger of equals to create diversified CNS leader","bullets":["Merger of equals under Agreement and Plan of Merger dated August 1, 2026.","Joint investor presentation and conference call held on August 3, 2026.","Transaction includes a special dividend and additional indebtedness; terms not disclosed.","Closing subject to stockholder and regulatory approvals; S-4 registration statement to be filed.","Combined company expected to have significant scale in CNS biopharmaceuticals."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-329618","json":"https://secwatch.observer/filing/0001193125-26-329618.json","markdown":"https://secwatch.observer/filing/0001193125-26-329618.md","text":"https://secwatch.observer/filing/0001193125-26-329618.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625297/000119312526329618/0001193125-26-329618-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625297/000119312526329618/d166865d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-03T12:35:09.826883+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}